Santhera Reports Closing of Juvantia Acquisition and Final Upfront Payment from Partner Biovail
05-Oct-2009 -
Santhera Pharmaceuticals announced the final closing of the acquisition of Oy Juvantia Pharma Ltd of Turku, Finland. Santhera issued 105,973 previously reserved shares from its authorized share capital to Juvantia investors, as announced when exercising its option to acquire Juvantia on August ...
dyskinesia
Finland
levodopa induced dyskinesia
+2